Extracellular raises investment from global Big Idea Ventures

Extracellular, a scale-up and development partner supporting cultivated meat companies, has secured investment from Big Idea Ventures, global leader in early-stage investments in the alternative protein sector.

CEO Update | 3 October 2022

We’ve moved out of our offices to enable the demolition of the Southside building in Victoria street. We are currently in interim offices and our new address is BioIndustry Association, LABs, Victoria House, Bloomsbury Way, London, WC1B 4DA. We say goodbye to Southside after over 11 years... Read on for an update on the Conservative Party and Labour Party conferences, Board Elections and TechBio UK Conference.

Astrea Bioseparations introduces Nereus LentiHERO™, a fit-for-purpose solution for lentiviral vector purification

First commercially available product to utilize AstreAdept, Astrea Bioseparations’ novel nanofiber-based membrane material

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.

Professor Jeffrey Pollard Macomics’ co-founding board member and chair of its SAB elected to the Academia Europaea

Macomics Ltd, a biotech company with world-leading expertise in macrophage biology, congratulates its co-founder Prof. Jeffery Pollard Ph.D. on his election to the Academia Europaea (the European Academy, AE). Prof. Pollard will be welcomed as a new at a ceremony during the 33rd Annual Conference of Academia Europaea, Building Bridges 2022, in Barcelona 27-27 October.

Stablepharma and BB-NCIPD Ltd (Bul Bio) sign exclusive supply agreement to produce the world’s first fridge-free Tetanus diphtheria vaccine

Stablepharma Ltd, the Fridge-free Vaccine Company and BB-NCIPD Ltd (Bul Bio) European vaccine manufacturer, are delighted to announce that we have signed a definitive agreement for the exclusive bulk supply and commercialisation of the Tetanus diphtheria vaccine, on September 20th, 2022.

New Kent partnership to supercharge STEM talent and enterprise of tomorrow

A leading university in the Kent and Medway region and the county’s largest science and innovation park have announced they are taking their collaboration to a whole new level.

Member Spotlight: Interview with Moderna

Following the announcement about the BioIndustry Association (BIA) reaching a new milestone of 500 member companies earlier this week, we spoke with Darius Hughes, UK General Manager at Moderna to learn more about the mRNA global player and his intentions behind joining the trade association’s membership.

New Alzheimer's drug from Biogen and Eisai is just the beginning

A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.

LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts

Pivotal partnership seeks to transform Cystic Fibrosis research.